跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,753 条关于
“miR-221-3p”
全部
6,753
临床试验
4,078
药物
1,841
机构
99
资讯
735
去年
Smart Hydrogel Achieves 90% Diabetic Wound Closure in 12 Days Through Novel miRNA Therapy
去年
HDAC Inhibition in Muscle Cells Enhances Bone Regeneration via Extracellular Vesicles
去年
Sanofi Invests in Resalis Therapeutics' miRNA-22 Inhibitor for Obesity Treatment
10个月前
OrthoPediatrics Secures FDA Approval for 3P Small-Mini Pediatric Plating System
去年
Circular RNAs Emerge as Promising Biomarkers and Therapeutic Targets in Colorectal Cancer Immunotherapy
去年
3P Innovation Launches Next-Generation DPI Filling Technology, Promising Faster Production of Inhalable Therapeutics
上个月
3P Innovation Delivers Custom Aseptic Reconstitutable Powder Filling System for Global MedTech Client
去年
CSF Biomarkers NfL, CHIT1, and miR-181b Evaluated for ALS Diagnosis and Prognosis
去年
EuMentis Therapeutics Receives FDA Clearance for Phase 2 Trial of Novel PDE10A Inhibitor EM-221 in Schizophrenia
去年
Exosomes Emerge as Dual-Purpose Tools in Cancer: From Drug Resistance Mechanisms to Therapeutic Delivery Systems
第 1 页,共 74 页
上一页
下一页